Recruitment of RECONNECT is complete
Learn more about a clinical trial evaluating an investigational treatment to see if it helps behavioural issues related to Fragile X syndrome.
Qualified participants are:
- Between 3 and 22 years of age
- Diagnosed via genetic testing, with Fragile X syndrome
- In generally good health
